Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology

J. L. Fleiss, J. T. Bigger, M. McDermott, J. P. Miller, T. Moon, A. J. Moss, D. Oakes, L. M. Rolnitzky, T. M. Therneau

Research output: Contribution to journalEditorial

16 Scopus citations
Original languageEnglish (US)
Pages (from-to)684-685
Number of pages2
JournalCirculation
Volume81
Issue number2
DOIs
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Fleiss, J. L., Bigger, J. T., McDermott, M., Miller, J. P., Moon, T., Moss, A. J., Oakes, D., Rolnitzky, L. M., & Therneau, T. M. (1990). Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. Circulation, 81(2), 684-685. https://doi.org/10.1161/01.CIR.81.2.684